China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds
June 21 (Reuters) - Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of 10% to 15% of their body weight, roughly in line with results from a similar drug sold by Novo Nordisk (NOVOb.CO), opens new tab, according to a late-stage study published on Saturday.
The drug, called ecnoglutide, belongs to a class of drugs that include Novo's Wegovy called GLP-1 receptor agonists, which work by helping control blood sugar levels and triggering a feeling of fullness.
"It's going to be competitive," said Dr. Tricia Tan of Imperial College London, who wrote a piece accompanying the data which appeared in medical journal The Lancet.
Tan said additional GLP-1s on the market could potentially drive prices down and improve access globally.
"It's great to have competition in the market. It's been extremely frustrating - I work in the National Health Service and patients are not getting access to these drugs."
Patients have seen even better results with Eli Lilly's (LLY.N), opens new tab Zepbound, which stimulates GLP-1 as well as a second gut hormone called GIP. More than 20% weight loss was reported in clinical trials.
According to the Sciwind Phase 3 study, 499 patients were given 1.2 mg, 1.8 mg or 2.4 mg of ecnoglutide as a subcutaneous injection once weekly for 48 weeks, with 165 patients assigned to receive a placebo. The study was conducted at 36 medical centers across China.
The patients who received the 1.2 mg dose lost an average of 9.9% of their body weight after 48 weeks, and those who received the 1.8 mg dose lost an average of 13.3% of their body weight. Patients on the 2.4 mg dose lost an average of 15.4% of their body weight.
The patients on placebo lost an average of 0.3% of their body weight over the period.
The side-effect profile is not significantly different from the other weight loss drugs. Many of the patients given ecnoglutide experienced decreased appetite and gastrointestinal problems, including diarrhea, nausea and vomiting, the study authors wrote.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
Animal welfare concerns halt hotel's panda wake-up service
A Chinese hotel's unique red panda wake-up service, where the animals visit guests' rooms and climb on beds, has been ordered to stop. The Chongqing Forestry Bureau mandated the halt due to concerns over animal welfare, potential injury, and disease transmission. The Lehe Ledu Liangjiang Holiday Hotel in Chongqing attracted many guests specifically for this popular interaction with its four resident red pandas. Animal rights experts, including Sun Quanhui from World Animal Protection, stated that red pandas are a nationally protected species and should not be used for entertainment, citing their sensitive nature. The forestry bureau is currently conducting an on-site investigation at the hotel and will release its findings.
The Guardian
3 hours ago
- The Guardian
Trump's plan to ban US states from AI regulation will ‘hold us back', says Microsoft science chief
Microsoft's chief scientist has warned that Donald Trump's proposed ban on state-level guardrails on artificial intelligence will slow the development of the frontier technology rather than accelerate it. Dr Eric Horvitz, a former technology adviser to Joe Biden, said bans on regulation will 'hold us back' and 'could be at odds with making good progress on not just advancing the science, but in translating it into practice'. The Trump administration has proposed a 10-year ban on US states creating 'any law or regulation limiting, restricting, or otherwise regulating artificial intelligence models, artificial intelligence systems, or automated decision systems'. It is driven in part by White House fears China could otherwise win the race to human-level AI, but also pressure from tech investors, such as Andreessen Horowitz, an early investor in Facebook, which argues consumer uses should be regulated rather than research efforts. Its co-founder, the Trump donor Marc Andreessen, said earlier this month that the US was in a two horse race for AI supremacy with China. The US vice-president, JD Vance, recently said: 'If we take a pause, does [China] not take a pause? Then we find ourselves … enslaved to [China]-mediated AI.' Horvitz said he was already concerned about 'AI being leveraged for misinformation and inappropriate persuasion' and for its use 'for malevolent activities, for example, in the biology biological hazard space'. Horvitz's pro-regulation comments came despite reports that Microsoft is part of a Silicon Valley lobbying push with Google, Meta and Amazon, to support the ban on individual US states regulating AI for the next decade which is included in Trump's budget bill which is passing through Congress. Microsoft is part of a lobbying drive to urge the US Senate to enact a decade-long moratorium on individual states introducing their own efforts to legislate, the Financial Times reported last week. The ban has been written into Trump's 'big beautiful bill' that he wants passed by Independence Day on 4 July. Horvitz was speaking at a meeting of the the Association for the Advancement of Artificial Intelligence on Monday when he said: 'It's up to us as scientists to communicate to government agencies, especially those right now who might be making statements about no regulation, [that] this is going to hold us back. 'Guidance, regulation … reliability controls are part of advancing the field, making the field go faster in many ways.' Speaking at the same seminar, Stuart Russell, the professor of computer science at the University of California, Berkeley, said: 'Why would we deliberately allow the release of a technology which even its creators say has a 10% to 30% chance … of causing human extinction? We would never accept anything close to that level of risk for any other technology.' Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion The apparent contradiction between Microsoft's chief scientist and reports of the company's lobbying effort comes amid rising fears that unregulated AI development could pose catastrophic risks to humanity and is being driven by companies prioritising short-term profit. Microsoft has invested $14bn (£10bn) in OpenAI, the developer of ChatGPT, whose chief executive Sam Altman who this week predicted that: 'In five or 10 years we will have great human robots and they will just walk down the street doing stuff … I think that would be one of the moments that … will feel the strangest.' Predictions of when human-level artificial general intelligence (AGI) will be reached vary from a couple of years to decades. The Meta chief scientist, Yann LeCun, has said AGI could be decades away, while last week his boss, Mark Zuckerberg, announced a $15bn investment in a bid to achieve 'superintelligence'. Microsoft declined to comment.
The Sun
4 hours ago
- The Sun
I lost half my bodyweight but it had nothing to do with Ozempic – a simple daily exercise helped me shed the pounds
A WOMAN has revealed how she lost 10 stone in two years without Ozempic thanks to one simple daily exercise. Hannah Mai, 37, was diagnosed with Cushing's disease - a hormonal disorder caused by prolonged exposure to high levels of cortisol - in October 2020, after gaining 10 stone in two and a half years. 8 8 8 Five months after her diagnosis, in February 2021, Hannah underwent brain surgery to remove the pituitary tumour that causes the condition, and was placed on steroids to control her condition. In April, 2023, Hannah was taken off her steroid medication and was determined to shed the 10 stone she gained due to the disease as she now weighed 20st 5lbs and was a size 26. In two years, Hannah slimmed down to 10 stone 4lbs and a size 10 by eating high-protein meals and doing pilates every day. Hannah, who is currently unemployed, from Coventry, Warwickshire, says: "I think Ozempic is great for people who need it, and for medical reasons. "It is really helping some people, but I feel if you give yourself a chance, you can really push yourself. "Once I started losing the weight, I just kept going. "It isn't easy, you really have to push yourself, and focus on who you want to be and think about who you want to be." When she turned 30, Hannah noticed she started gaining weight and went from nine stone to 16 stone in a few months. She said she kept going to the doctor, but would always be asked if she was pregnant, or the weight gain was blamed on hormones. Hannah says: "I was always around nine stone, but I noticed how I started to gain a bit of weight. "I knew there was something wrong with me, but people around me thought I had changed my diet and asked if I was eating more. "I was asked if I was pregnant six times, and told that my weight gain could be caused by hormones. "I went up to 20 stone at my heaviest." In October 2020, more than two years after she started gaining weight, Hannah woke up one morning with a hunched back. Hannah googled the cause, and it mentioned Cushing's disease, and after seeing the other symptoms - including weight gain - she went straight to the doctor. The doctor transferred her to University Hospital Coventry & Warwickshire, where an MRI scan and blood test confirmed she had Cushing's disease. Hannah says: "I printed off the list of symptoms and took them to my doctor, who then referred me to the hospital. "There, I had an MRI scan and blood tests, which confirmed that I had Cushing's disease. 8 8 8 "I was relieved but scared when I got the diagnosis. I had been saying for years that there was something wrong with me." Five months after her diagnosis, in February 2021, Hannah underwent brain surgery to remove the pituitary tumour that causes the condition, and was placed on steroids to control her condition. Then, after two years on steroid medication -to control her condition - Hannah was taken off her meds because she started to get better. After she came off her medication, Hannah says she knew she was better and became determined to lose weight. The 5 best exercises to lose weight By Lucy Gornall, personal trainer and health journalist EXERCISE can be intimidating and hard to devote yourself to. So how do you find the right workout for you? As a PT and fitness journalist, I've tried everything. I've taken part in endless fitness competitions, marathons and I maintain a regime of runs, strength training and Pilates. Fitness is so entrenched in my life, I stick to it even at Christmas! The key is finding an activity you love that can become a habit. My top five forms of exercise, especially if you're trying to lose weight, are: Walking Running Pilates High-intensity interval training (HIIT) Strength training She adds: "It wasn't easy to lose weight whilst I was still on steroids, as soon as I came off them, I knew this was my body and I was a lot better. "I really pushed myself, I worked super hard, cut out all sugar, cut out dairy, and gluten after I was diagnosed with celiac disease "I have a low-carb, high-protein diet with lots of vegetables, and I do pilates every day." In two years, Hannah was able to shift the pounds going down to 10 stone from 20 stone. She went from wearing a size 26 clothes to wearing a size 10 - back to where she was before Cushing's disease. Hannah says: "I am super proud of myself, I am always worried that the weight will come back. "I feel so much happier. When I look back at myself, I just can't believe I was that size. "When I look back at old photos, I feel very sad about what happened to me, but it makes me think that I need to be proud about how far I have come." Hannah is currently raising money for The Pituitary Foundation, to donate click here 8 8
